Home > Financial Ratios > TTK HEALTHCARE

TTK HEALTHCARE
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for TTK HEALTHCARE
Please provide your vote to see the results

TTK HEALTHCARE Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 25.42108.7630.47-21.08-35.31

What is the latest Core EBITDA Growth ratio of TTK HEALTHCARE ?

The latest Core EBITDA Growth ratio of TTK HEALTHCARE is 25.42 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202425.42
Mar2023108.76
Mar202230.47
Mar2021-21.08
Mar2020-35.31

How is Core EBITDA Growth of TTK HEALTHCARE Trending?

Years Core EBITDA Growth % Change
Mar2024 25.42
-76.63
Mar2023 108.76
256.94
Mar2022 30.47
Positive
Mar2021 -21.08
Negative
Mar2020 -35.31 -

Other Financial Ratios of TTK HEALTHCARE


Compare Core EBITDA Growth ratio of peers of TTK HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TTK HEALTHCARE ₹1,745.6 Cr 0.9% -7.6% -18.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,223.0 Cr -4.1% -9.8% 8.2% Stock Analytics
DIVIS LABORATORIES ₹152,610.0 Cr -2.9% -0.3% 63.8% Stock Analytics
CIPLA ₹119,067.0 Cr 0.1% 4.4% 2.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹102,744.0 Cr -1.3% -6.5% 19% Stock Analytics
DR REDDYS LABORATORIES ₹96,123.8 Cr -4% -5.9% -7.8% Stock Analytics


TTK HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

0.9%

-7.6%

-18.4%

SENSEX

-0.8%

-1.6%

3.1%


You may also like the below Video Courses